After a seven-year battle between two biotechnology companies for fees involving the lease of antibody technology, lessor Bioquest received a $2.5 million judgment recently from a Los Angeles jury.

The award, handed down in April in Bioquest Venture Leasing v. VivoRx Autoimmune, will ultimately come out of the pockets of one of the nation’s richest. Patrick Soon-Shiong is ranked 116th on Forbes‘ list of the country’s 400 richest people, showing a net worth of $2.2 billion.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]